共 114 条
[1]
(2003)
[2]
Eltabbakh G.H., Awtrey C.S., Current treatment for ovarian cancer, Expert Opin. Pharmacother., 2, pp. 109-124, (2001)
[3]
Yuan Z.Q., Sun M., Feldman R.I., Wang G., Ma X., Jiang C., Coppola D., Nicosia S.V., Cheng J.Q., Frequent activation of AKT2 induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer, Oncogene, 19, pp. 2324-2330, (2000)
[4]
Lasky T., Silbergeld E., P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers, Environ. Health Perspect., 104, pp. 1324-1331, (1996)
[5]
Gatti L., Supino R., Perego P., Pavesi R., Caserini C., Carenini N., Righetti S.C., Zuco V., Zunino F., Apoptosis growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response, Cell Death Differ., 9, pp. 1352-1359, (2002)
[6]
Servidei T., Ferlini C., Riccardi A., Meco D., Scambia G., Segni G., Manzotti C., Riccardi R., The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin, Eur. J. Cancer, 37, pp. 930-938, (2001)
[7]
Schneiderman D., Kim J.-M., Senterman M., Tsang B.K., Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells, Apoptosis, 4, pp. 271-282, (1999)
[8]
Li J., Feng Q., Kim J.M., Schneiderman D., Liston P., Li M., Vanderhyden B., Faught W., Fung M.F., Senterman M., Korneluk R.G., Tsang B.K., Human ovarian cancer cisplatin resistance: Possible role of inhibitor of apoptosis proteins, Endocrinology, 142, pp. 370-380, (2001)
[9]
Jesenberger V., Jentsch S., Deadly encounter: Ubiquitin meets apoptosis, Nat. Rev. Mol. Cell Biol., 3, pp. 112-121, (2002)
[10]
Verhagen A.M., Coulson E.J., Vaux D.L., Inhibitor of apoptosis proteins their relatives: IAPs other BIRPs, Genome. Biol., 2, (2001)